Notably, we assessed one such case (Patient #19, Table 1), and this cancer had loss of RB and EGFR expression, similar to the cases of EGFR mutant SCLC observed in the setting of acquired resistance to EGFR TKI. This evidence concerns the gene EGFR and cancer.